Listen and follow our podcasts on:

This educational programme is supported by an Independent Educational Grant from Ipsen

Prof. Anna Teti (University of L'Aquila) shares rare bone disease highlights from the ASBMR 2022 Annual Meeting. A downloadable educational infographic summarizes her podcast highlights.

 

In this episode, Prof. Anna Teti reviews key developments from the Rare Diseases Symposium held September 8th, 2022. The goal of the Symposium was to promote interaction between basic, translational and clinical researchers in the rare bone disease field. Her podcast touches on several themes relevant to clinicians and patients. These include active clinical research studies, adverse events monitoring, and the importance of collaboration to advance work in the field.

 

ASBMR logo

 

This educational activity was developed in partnership between COR2ED and the American Society for Bone and Mineral Research, supported by an independent medical education grant from the Rare Bone Disease Consortium, represented by Alexion, AstraZeneca Rare Disease, by Ipsen and by Kyowa Kirin, who had no input into selection of topics or speakers.

Prof. Anna Teti has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Prof. Anna Teti has no disclosures to declare.

Listen and follow our podcasts on:

This educational programme is supported by an Independent Educational Grant from Ipsen

Prof. Anna Teti (University of L'Aquila) shares rare bone disease highlights from the ASBMR 2022 Annual Meeting. A downloadable educational infographic summarizes her podcast highlights.

 

In this episode, Prof. Anna Teti reviews key developments from the Rare Diseases Symposium held September 8th, 2022. The goal of the Symposium was to promote interaction between basic, translational and clinical researchers in the rare bone disease field. Her podcast touches on several themes relevant to clinicians and patients. These include active clinical research studies, adverse events monitoring, and the importance of collaboration to advance work in the field.

 

ASBMR logo

 

This educational activity was developed in partnership between COR2ED and the American Society for Bone and Mineral Research, supported by an independent medical education grant from the Rare Bone Disease Consortium, represented by Alexion, AstraZeneca Rare Disease, by Ipsen and by Kyowa Kirin, who had no input into selection of topics or speakers.

Prof. Anna Teti has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Prof. Anna Teti has no disclosures to declare.

Programme summary
Listen to the podcast now
Other episodes of this series
ASBMR 2022 Rare Bone Disease Highlights

ASBMR 2022 Rare Bone Disease Highlights

Episode 1: Discover expert insights from the Rare Diseases Symposium

Current Episode
ASBMR 2022 Rare Bone Disease Highlights

ASBMR 2022 Rare Bone Disease Highlights

Episode 2: Clinician Perspective

ASBMR 2022 Rare Bone Disease Highlights

ASBMR 2022 Rare Bone Disease Highlights

Episode 3: Patient Advocate Perspective

Share this programme
This educational programme is supported by an Independent Educational Grant from Ipsen
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Ipsen
I agree that this educational programme:

Was valuable to me

1/4
Programme summary
  • clock Duration MIN
  • clock Language(s) flag
Listen to the podcast now
Other episodes of this series
ASBMR 2022 Rare Bone Disease Highlights

ASBMR 2022 Rare Bone Disease Highlights

Episode 1: Discover expert insights from the Rare Diseases Symposium

Current Episode
ASBMR 2022 Rare Bone Disease Highlights

ASBMR 2022 Rare Bone Disease Highlights

Episode 2: Clinician Perspective

ASBMR 2022 Rare Bone Disease Highlights

ASBMR 2022 Rare Bone Disease Highlights

Episode 3: Patient Advocate Perspective

Share this programme
This educational programme is supported by an Independent Educational Grant from Ipsen
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Ipsen
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

animated-video Animated Video
Endocrinology Rare diseases Bone diseases 
Rethinking hypophosphatasia (HPP) and systemic impacts of deficient alkaline phosphatase activity

Understanding the mechanism of disease of hypophosphatasia

  • clock 4 MIN
  • calendar May 2025

This programme has been initiated and funded by Alexion Pharmaceuticals and is intended for healthcare professionals only.  The Alexion logo is a registered trademark of Alexion Pharmaceuticals, Inc.©2024 Alexion Pharmaceuticals, Inc. All rights reserved.GL/UNB-H/0063 – May 2025  
podcast Video podcast

Episode

3

of 3

episode
Bone diseases 
ASBMR 2022 Rare Bone Disease Highlights

Episode 3: Patient Advocate Perspective

Experts
Prof. Eric Rush, Ms. Inês Alves, Ms. Tracy Hart
  • download Downloadable
    Resources
  • clock MIN
  • calendar Sep 2022

This educational programme is supported by an Independent Educational Grant from Ipsen
podcast Video podcast

Episode

2

of 3

episode
Bone diseases 
ASBMR 2022 Rare Bone Disease Highlights

Episode 2: Clinician Perspective

Experts
Prof. Eric Rush, Ms. Inês Alves, Ms. Tracy Hart
  • download Downloadable
    Resources
  • clock MIN
  • calendar Sep 2022

This educational programme is supported by an Independent Educational Grant from Ipsen